academic article

• Magidson, J., Bradley, V., Anane, J., Kleinman, M., Felton, J., Hines, A., Baskar, R., Greenblatt, A., Dean, D., Anvari, M., Fitzsimons, H., Bennett, M., & Belcher, A. (2025). "HEAL together": a randomized, hybrid type 1 effectiveness-implementation trial protocol of a peer-delivered behavioral activation intervention to improve methadone treatment retention.. 10.3389/fpubh.2025.1637846
• Bradley, V., Kleinman, M., Anvari, M., Abidogun, T., Seitz-Brown, C., Belcher, A., Cole, T., Greenblatt, A., & Magidson, J. (2025). "It's more than just the act of not using. It's a feeling of finally completing something.": Person-centered definitions of successful treatment outcomes from patients and staff at a methadone treatment program in Baltimore City.. 10.1016/j.josat.2025.209683
• McLean, K., Kruis, N., Weintraub, E., Fitzsimons, H., Welsh, C., Spicyn, N., Kearley, B., Altekruse, W., Rowland, N., & Belcher, A. (2025). A mixed-method exploratory assessment of provider-based stigma of opioid use disorder (OUD) and support for medications for opioid use disorder (MOUD) in carceral settings.. 10.1186/s12954-025-01291-z
• Manza, P., Belcher, A., Fitzsimons, H., Spaderna, M., Greenblatt, A., Smith, H., Derenoncourt, M., Gann, D., Farooq, U., Kvarta, M., DiPaula, B., Merritt, S., Mitic, I., Zarate, C., Gould, T., Weintraub, E., & Kattakuzhy, S. (2025). Ketamine to enhance methadone treatment retention in patients with opioid use disorder and co-morbid depression.. The American Journal of Drug and Alcohol Abuse 10.1080/00952990.2025.2541212
• Spaderna, M., Belcher, A., Welsh, C., Smith, H., Fitzsimons, H., Coble, K., Spicyn, N., Rosenthal, E., Liu, T., & Weintraub, E. (2025). Telemedicine Buprenorphine Access For Incarcerated People: Lessons Learned From Maryland's Rural Jails.. Health Affairs, 44(9), 1131-1137. 10.1377/hlthaff.2025.00339
• Israel, B., Belcher, A., & Ford, J. (2024). A Harm Reduction Framework for Integrated Treatment of Co-Occurring Opioid Use Disorder and Trauma-Related Disorders.. 10.1080/15504263.2023.2295416
• Belcher, A., Kearley, B., Kruis, N., Rowland, N., Spicyn, N., Cole, T., Welsh, C., Fitzsimons, H., McLean, K., & Weintraub, E. (2024). Correlates of Staff Acceptability of a Novel Telemedicine-Delivered Medications for Opioid Use Disorder Program in a Rural Detention Center.. Journal of Correctional Health Care, 30(4), 238-244. 10.1089/jchc.23.11.0097
• Wish, E., Billing, A., Massey, E., Cole, T., Greenblatt, A., Weintraub, E., Dohlman, P., & Belcher, A. (2024). On the Value of Measuring Recent Drug Use by Self-Reports and Urinalysis in Clinical Trials.. Substance Use & Misuse, 59(14), 2112-2115. 10.1080/10826084.2024.2401341
• Kleinman, M., Anvari, M., Felton, J., Bradley, V., Belcher, A., Abidogun, T., Hines, A., Dean, D., Greenblatt, A., Wagner, M., Earnshaw, V., & Magidson, J. (2024). Reduction in substance use stigma following a peer-recovery specialist behavioral activation intervention.. International Journal of Drug Policy, 130, 104511. 10.1016/j.drugpo.2024.104511
• Ferré, S., Winkelman, J., García-Borreguero, D., Belcher, A., Chang, J., & Earley, C. (2024). Restless legs syndrome, neuroleptic-induced akathisia, and opioid-withdrawal restlessness: shared neuronal mechanisms?. Sleep, 47(3). 10.1093/sleep/zsad273
• Kacmarek, C., Smith, H., Kuehn, M., Bennett, M., Belcher, A., Fitzsimons, H., Hall, W., Greenblatt, A., Li, L., & Travaglini, L. (2024). The impact of chronic pain and depression on medication for opioid use disorder treatment: A mixed-methods analysis.. Heroin addiction and related clinical problems, 26. 10.62401/2531-4122-2024-15
• Belcher, A., Cole, T., Massey, E., Billing, A., Wagner, M., Wooten, W., Epstein, D., Hoag, S., Wickwire, E., Greenblatt, A., Colloca, L., Rotrosen, J., Magder, L., Weintraub, E., Wish, E., & Kaptchuk, T. (2023). Effectiveness of Conditioned Open-label Placebo With Methadone in Treatment of Opioid Use Disorder: A Randomized Clinical Trial.. 10.1001/jamanetworkopen.2023.7099
• Abidogun, T., Cole, T., Massey, E., Kleinman, M., Greenblatt, A., Seitz-Brown, C., Magidson, J., & Belcher, A. (2023). Patient experiences of COVID-19-induced changes to methadone treatment in a large community-based opioid treatment program in Baltimore.. Journal of substance use and addiction treatment, 145, 208946. 10.1016/j.josat.2022.208946
• Kleinman, M., Anvari, M., Seitz-Brown, C., Bradley, V., Tralka, H., Felton, J., Belcher, A., Greenblatt, A., & Magidson, J. (2023). Psychosocial challenges affecting patient-defined medication for opioid use disorder treatment outcomes in a low-income, underserved population: Application of the social-ecological framework.. Journal of substance use and addiction treatment, 149, 209046. 10.1016/j.josat.2023.209046
• Anvari, M., Kleinman, M., Massey, E., Bradley, V., Felton, J., Belcher, A., & Magidson, J. (2022). "In their mind, they always felt less than": The role of peers in shifting stigma as a barrier to opioid use disorder treatment retention.. Journal of Substance Abuse Treatment 10.1016/j.jsat.2022.108721
• Magidson, J., Kleinman, M., Bradley, V., Anvari, M., Abidogun, T., Belcher, A., Greenblatt, A., Dean, D., Hines, A., Seitz-Brown, C., Wagner, M., Bennett, M., & Felton, J. (2022). Peer recovery specialist-delivered, behavioral activation intervention to improve retention in methadone treatment: Results from an open-label, Type 1 hybrid effectiveness-implementation pilot trial.. International Journal of Drug Policy, 108, 103813. 10.1016/j.drugpo.2022.103813
• Clifton, J., Belcher, A., Greenblatt, A., Welsh, C., Cole, T., & Davis, A. (2022). Psilocybin use patterns and perception of risk among a cohort of Black individuals with Opioid Use Disorder.. 10.1556/2054.2022.00214
• Clark, A., Goodwin, S., Marks, R., Belcher, A., Heinlein, E., Bennett, M., & Roche, D. (2021). A Narrative Literature Review of the Epidemiology, Etiology, and Treatment of Co-Occurring Panic Disorder and Opioid Use Disorder.. Journal of dual diagnosis, 17(4), 313-332. 10.1080/15504263.2021.1965407
• Belcher, A., Coble, K., Cole, T., Welsh, C., Whitney, A., & Weintraub, E. (2021). Buprenorphine Induction in a Rural Maryland Detention Center During COVID-19: Implementation and Preliminary Outcomes of a Novel Telemedicine Treatment Program for Incarcerated Individuals With Opioid Use Disorder.. 10.3389/fpsyt.2021.703685
• Weintraub, E., Seneviratne, C., Anane, J., Coble, K., Magidson, J., Kattakuzhy, S., Greenblatt, A., Welsh, C., Pappas, A., Ross, T., & Belcher, A. (2021). Mobile Telemedicine for Buprenorphine Treatment in Rural Populations With Opioid Use Disorder.. 10.1001/jamanetworkopen.2021.18487
• Weintraub, E., Greenblatt, A., Chang, J., Welsh, C., Berthiaume, A., Goodwin, S., Arnold, R., Himelhoch, S., Bennett, M., & Belcher, A. (2021). Outcomes for patients receiving telemedicine-delivered medication-based treatment for Opioid Use Disorder: A retrospective chart review.. Heroin addiction and related clinical problems, 23(2), 5-12.
• Deutsch-Link, S., Belcher, A., Massey, E., Cole, T., Wagner, M., Billing, A., Greenblatt, A., Weintraub, E., & Wish, E. (2021). Race-based differences in drug use prior to onset of opioid use disorder.. Journal of Ethnicity in Substance Abuse 10.1080/15332640.2021.1879702
• Greenblatt, A., Magidson, J., Belcher, A., Gandhi, D., & Weintraub, E. (2020). Overdue for an Overhaul: How Opioid Treatment Programs Can Learn From COVID-19.. Mayo Clinic proceedings, 95(10), 2076-2078. 10.1016/j.mayocp.2020.08.011
• Cole, T., Robinson, D., Kelley-Freeman, A., Gandhi, D., Greenblatt, A., Weintraub, E., & Belcher, A. (2020). Patient Satisfaction With Medications for Opioid Use Disorder Treatment via Telemedicine: Brief Literature Review and Development of a New Assessment.. 10.3389/fpubh.2020.557275
• Belcher, A., Cole, T., Greenblatt, A., Hoag, S., Epstein, D., Wagner, M., Billing, A., Massey, E., Hamilton, K., Kozak, Z., Welsh, C., Weintraub, E., Wish, E., Kaptchuk, T., & Colloca, L. (2019). Open-label dose-extending placebos for opioid use disorder: a protocol for a randomised controlled clinical trial with methadone treatment.. 10.1136/bmjopen-2018-026604
• Cai, N., Quiroz, C., Bonaventura, J., Bonifazi, A., Cole, T., Purks, J., Billing, A., Massey, E., Wagner, M., Wish, E., Guitart, X., Rea, W., Lam, S., Moreno, E., Casadó-Anguera, V., Greenblatt, A., Jacobson, A., Rice, K., Casadó, V., ... , , , , , , & Ferré, S. (2019). Opioid-galanin receptor heteromers mediate the dopaminergic effects of opioids.. The Journal of clinical investigation, 129(7), 2730-2744. 10.1172/jci126912
• Belcher, A., Ferré, S., Martinez, P., & Colloca, L. (2018). Role of placebo effects in pain and neuropsychiatric disorders.. Progress in neuro-psychopharmacology & biological psychiatry, 87(Pt B), 298-306. 10.1016/j.pnpbp.2017.06.003
• Vaupel, D., Schindler, C., Chefer, S., Belcher, A., Ahmet, I., Scheidweiler, K., Huestis, M., & Stein, E. (2016). Delayed emergence of methamphetamine's enhanced cardiovascular effects in nonhuman primates during protracted methamphetamine abstinence.. Drug and Alcohol Dependence, 159, 181-9. 10.1016/j.drugalcdep.2015.12.008
• Belcher, A., Yen, C., Notardonato, L., Ross, T., Volkow, N., Yang, Y., Stein, E., Silva, A., & Tomasi, D. (2016). Functional Connectivity Hubs and Networks in the Awake Marmoset Brain.. 10.3389/fnint.2016.00009
• Fishbein, D., Rose, E., Darcey, V., Belcher, A., & VanMeter, J. (2016). Neurodevelopmental Precursors and Consequences of Substance Use during Adolescence: Promises and Pitfalls of Longitudinal Neuroimaging Strategies.. 10.3389/fnhum.2016.00296
• Yang, S., Belcher, A., Chefer, S., Vaupel, D., Schindler, C., Stein, E., & Yang, Y. (2015). Withdrawal from long-term methamphetamine self-administration 'normalizes' neurometabolites in rhesus monkeys: a (1) H MR spectroscopy study.. Addiction biology, 20(1), 69-79. 10.1111/adb.12078
• Belcher, A., Volkow, N., Moeller, F., & Ferré, S. (2014). Personality traits and vulnerability or resilience to substance use disorders.. Trends in cognitive sciences, 18(4), 211-7. 10.1016/j.tics.2014.01.010
• Belcher, A., Yen, C., Stepp, H., Gu, H., Lu, H., Yang, Y., Silva, A., & Stein, E. (2013). Large-scale brain networks in the awake, truly resting marmoset monkey.. The Journal of neuroscience : the official journal of the Society for Neuroscience, 33(42), 16796-804. 10.1523/jneurosci.3146-13.2013
• Izquierdo, A., & Belcher, A. (2012). Rodent models of adaptive decision making.. Methods in molecular biology (Clifton, N.J.), 829, 85-101. 10.1007/978-1-61779-458-2_5
• Feifel, D., Shilling, P., & Belcher, A. (2012). The effects of oxytocin and its analog, carbetocin, on genetic deficits in sensorimotor gating.. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 22(5), 374-8. 10.1016/j.euroneuro.2011.09.004
• Belcher, A., & Sinnott-Armstrong, W. (2010). Neurolaw.. Wiley interdisciplinary reviews. Cognitive science, 1(1), 18-22. 10.1002/wcs.8
• Izquierdo, A., Belcher, A., Scott, L., Cazares, V., Chen, J., O'Dell, S., Malvaez, M., Wu, T., & Marshall, J. (2010). Reversal-specific learning impairments after a binge regimen of methamphetamine in rats: possible involvement of striatal dopamine.. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 35(2), 505-14. 10.1038/npp.2009.155
• Belcher, A., O'Dell, S., & Marshall, J. (2009). Long-term changes in dopamine-stimulated gene expression after single-day methamphetamine exposure.. Synapse (New York, N.Y.), 63(5), 403-12. 10.1002/syn.20617
• Belcher, A., Feinstein, E., O'Dell, S., & Marshall, J. (2008). Methamphetamine influences on recognition memory: comparison of escalating and single-day dosing regimens.. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 33(6), 1453-63. 10.1038/sj.npp.1301510
• Marshall, J., Belcher, A., Feinstein, E., & O'Dell, S. (2007). Methamphetamine-induced neural and cognitive changes in rodents.. Addiction, 102 Suppl 1, 61-9. 10.1111/j.1360-0443.2006.01780.x
• Belcher, A., O'Dell, S., & Marshall, J. (2006). A sensitizing regimen of methamphetamine causes impairments in a novelty preference task of object recognition.. Behavioural brain research, 170(1), 167-72. 10.1016/j.bbr.2006.02.025
• Belcher, A., Harrington, R., Malkova, L., & Mishkin, M. (2006). Effects of hippocampal lesions on the monkey's ability to learn large sets of object-place associations.. Hippocampus, 16(4), 361-7. 10.1002/hipo.20147
• Belcher, A., O'Dell, S., & Marshall, J. (2005). Impaired object recognition memory following methamphetamine, but not p-chloroamphetamine- or d-amphetamine-induced neurotoxicity.. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 30(11), 2026-34. 10.1038/sj.npp.1300771
• Cahill, L., Gorski, L., Belcher, A., & Huynh, Q. (2004). The influence of sex versus sex-related traits on long-term memory for gist and detail from an emotional story.. Consciousness and cognition, 13(2), 391-400. 10.1016/j.concog.2003.11.003